Crocs, Inc.

Informe acción NasdaqGS:CROX

Capitalización de mercado: US$6.3b

Crocs Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Los beneficios de Crocs han disminuido a una tasa media anual de -13.3%, mientras que en la industria Luxury los beneficios disminuyeron en un 1.1% anualmente. Los ingresos han ido creciendo a una tasa media de 11.6% al año. La rentabilidad financiera de Crocs es de 42.9%, y sus márgenes netos son de 14.6%.

Información clave

-13.32%

Tasa de crecimiento de los beneficios

-11.07%

Tasa de crecimiento del BPA

Crecimiento de la industria Luxury 12.25%
Tasa de crecimiento de los ingresos11.59%
Rentabilidad financiera42.86%
Margen neto14.63%
Última actualización de beneficios30 Jun 2026

Actualizaciones de resultados anteriores recientes

Artículo de análisis Aug 14

Crocs' (NASDAQ:CROX) Conservative Accounting Might Explain Soft Earnings

Investors were disappointed with the weak earnings posted by Crocs, Inc. ( NASDAQ:CROX ). However, our analysis...

Recent updates

Actualización de narrativa Aug 04

CROX: Weak Q3 Outlook And Macro Risks Will Pressure Future Returns

Crocs' analyst fair value estimate has been revised higher from $86.0 to $95.0 as analysts point to improving demand trends in North America, early signs of a recovery at HeyDude, and expectations for a higher future P/E multiple despite a more cautious macro backdrop. Analyst Commentary Recent research on Crocs highlights a mix of optimism on demand trends and caution on how much of that improvement is already reflected in the stock price.
Seeking Alpha Aug 01

Crocs: My Target Was Hit-- Downgrading To Hold After Taking The Win

Summary Crocs, Inc. (CROX) reached my $140 target as the deleveraging and buyback catalyst played out; the stock now trades near $128 with growth slowing sharply. Despite beating Q2 expectations, CROX fell 7% as management guided Q3 to flat revenue with compressing margins, exposing a lack of near-term growth drivers. CROX trades at a low 9.75x forward earnings, but minimal forward growth, falling free cash flow, and HEYDUDE weakness leave it cheap without a catalyst, not a buy. I downgrade CROX to Hold: downside is limited by profitability and buybacks, but absent a growth catalyst, patience is warranted. Read the full article on Seeking Alpha
Actualización de narrativa Jul 21

CROX: DTC Momentum And HeyDude Recovery Will Support Future Multiple Expansion

The analyst fair value estimate for Crocs has moved from $130 to $160. Analysts point to improving North America direct-to-consumer momentum, early signs of recovery in HeyDude, and a view that current earnings expectations and valuation remain attractive.
Nueva narrativa Jul 15

Crocs will step into the future with revenue growth

Valuation Switching to the bull scenario (revenue growth 5.5%, FCF margin expanding to 25%, 12x exit multiple, WACC 8.5%): Intrinsic value: ~$316/share — about +142% upside vs. the current $130.46 price.
Actualización de narrativa Jul 06

CROX: North America Recovery And Cash Returns Will Drive Balanced Risk Reward

Analysts have nudged their Crocs fair value estimate higher from $114.33 to $126.00, pointing to improving North America direct-to-consumer trends; early signs of recovery at HeyDude; slightly firmer revenue growth assumptions; and a modestly higher future P/E multiple as key supports for the higher price targets seen across recent upgrades. Analyst Commentary Bullish analysts see the recent upgrades and higher price targets as a reflection of improving fundamentals at Crocs, especially in North America and at HeyDude, and are framing the stock as a play on execution around growth, cost control, and earnings quality.
Actualización de narrativa Jun 22

CROX: Slower Turnaround And Cost Discipline Risks Will Pressure Future Earnings

Crocs' analyst price targets have moved higher, with several firms lifting their views by $1 to as much as $35, as analysts point to improving North America trends, tighter cost controls, and steadier demand signals across the Crocs and HeyDude brands. Analyst Commentary Recent research on Crocs centers on whether the current setup justifies higher valuation multiples, as analysts weigh improving North America trends against execution risks in the broader portfolio and the timing of any revenue reacceleration.
Artículo de análisis Jun 22

Crocs (CROX) Stock Could Be 26% Below Fair Value After TikTok Shop Push

Crocs (CROX) is testing a fresh twist on social commerce with Déjà Shoe, a seven episode TikTok microdrama that lets viewers shop tagged products directly inside the series. See our latest analysis for Crocs. Crocs shares trade at $125.05, with a 30 day share price return of 13.23% and a 90 day share price return of 56.92%, while the 1 year total shareholder return of 26.93% suggests recent momentum has been stronger than longer term gains. If Crocs’ social commerce push has your attention,...
Actualización de narrativa Jun 08

CROX: Cash Returns And North America Execution Will Shape Risk Reward Balance

Analysts have nudged their fair value estimate for Crocs up by about $1.70 to $114.33, reflecting increased confidence in sustainable North America and HeyDude momentum, tighter cost controls, and the potential for earnings upside highlighted in recent price target upgrades across the Street. Analyst Commentary Recent research on Crocs highlights a mix of optimism around the growth outlook and ongoing caution around execution risk, especially tied to North America and the HeyDude brand.
Actualización de narrativa May 25

CROX: Slower North America Turnaround Will Pressure Margins Despite Recent Optimism

Crocs' internal fair value estimate has moved from $71 to $86 as analysts factor in updated assumptions on revenue trends, margins and future P/E, supported by a series of recent price target raises and rating upgrades citing improving demand and inventory reset efforts. Analyst Commentary Recent research on Crocs includes several higher price targets and rating upgrades, alongside a cluster of more cautious views that focus on execution risk and the timing of any growth inflection.
Actualización de narrativa May 04

CROX: Rating Shifts And Buybacks Will Frame Execution Risk And Demand Recovery

Analysts have lifted their blended fair value estimate for Crocs stock from $108.25 to about $112.67. They point to updated assumptions around revenue growth, profit margins, and future P/E multiples that align with a recent series of price target increases and rating upgrades across the Street.
Actualización de narrativa Apr 20

CROX: Mixed Rating Shifts And Buybacks Will Shape Balanced Risk Reward Outlook

The analyst price target for Crocs has been adjusted from $102.91 to $108.25 as analysts balance improved demand signals and a slightly lower discount rate with more conservative assumptions on profit margins and future P/E multiples. Analyst Commentary Recent research on Crocs shows a mix of optimism around demand trends and brand reset efforts, alongside caution on valuation, margins and execution risk.
Actualización de narrativa Apr 05

CROX: Tariff Relief And DTC Focus Will Support Future Margin Resilience

Analyst price targets for Crocs have been revised modestly higher to $130.00, with analysts pointing to valuation support after the recent selloff, more balanced views on revenue and margin potential, and recognition of both tariff relief and ongoing competitive and wholesale headwinds. Analyst Commentary Recent research on Crocs reflects a mix of caution and renewed interest, with several bullish analysts highlighting valuation support after the share price pullback and incremental positives around tariffs and brand execution.
Actualización de narrativa Mar 22

CROX: Inventory Reset And DTC Focus Will Drive Future Rebound

Analysts have modestly lifted the fair value estimate for Crocs to $130, reflecting updated views on revenue growth, profit margins, and the stock's P/E outlook in light of recent rating changes and price target revisions across the Street. Analyst Commentary Recent Street research around Crocs has been mixed, but there are several clear pockets of optimism that help frame the updated fair value view.
Actualización de narrativa Mar 08

CROX: Mixed Rating Shifts And Buybacks Will Support Future Upside

Crocs' updated analyst price target edges higher to $102.91, as analysts weigh a series of recent target hikes in the $9 to $23 range alongside new downgrades that highlight more mixed sentiment around the stock. Analyst Commentary Analyst views on Crocs are split, with several firms lifting price targets while others move to more cautious ratings.
Actualización de narrativa Feb 22

CROX: Mixed Rating Shifts And Buybacks Will Steady Fairly Valued Shares

The analyst fair value estimate for Crocs has increased by about $13 to $102.91, as analysts weigh a mix of fresh price target increases and several recent downgrades in their updated assumptions. Analyst Commentary Recent Street research on Crocs reflects a mixed tone, with some firms lifting price targets while others are stepping back or turning more cautious.
Actualización de narrativa Feb 08

CROX: Promotional Pullback And Holiday Deals Will Pressure Near-Term Margins

Our analyst price target for Crocs is unchanged at US$71.00, as mixed recent research updates and a slightly higher discount rate are offset by analyst expectations for stronger profit margins and a lower forward P/E assumption. Analyst Commentary Street research on Crocs has been mixed recently, with several bearish analysts reducing their stance on the shares even as some are turning slightly more constructive.
Actualización de narrativa Jan 25

CROX: Mixed Ratings And Promotion Reset Will Guide Fairly Valued Shares

Narrative update on Crocs The analyst price target for Crocs has been reset lower from $100 to $89.75, as analysts balance softer projected revenue growth and profit margins with mixed rating changes and ongoing promotional and growth initiatives that they see as supportive for the business over the longer term. Analyst Commentary Recent Street research on Crocs paints a mixed picture, with some analysts becoming more cautious while others move from an outright negative stance to a more balanced view.
Actualización de narrativa Jan 10

CROX: Mixed Ratings And Promotion Pullback Will Shape Fairly Valued Shares

Analysts kept their fair value estimate for Crocs steady at US$89.75, with only minor tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions. This reflects a mixed but more balanced set of views after recent rating shifts and channel checks across the U.S. and China.
Actualización de narrativa Dec 26

CROX Initiatives Will Pressure Near-Term Results And Limit Upside Potential

Analysts have nudged their fair value estimate for Crocs higher from $67 to $71 per share, reflecting greater confidence in the company’s improving profitability and long-term earnings power despite near-term pressures from strategic initiatives and more cautious sentiment in recent checks. Analyst Commentary Bearish analysts acknowledge that Crocs is pursuing strategic initiatives aimed at strengthening the brand and improving long term profitability, but they see these efforts as a headwind to near term execution and financial visibility.
Actualización de narrativa Dec 11

CROX Shares Will Reflect U.S. Demand Reset And Promotion Pullback Over Time

Analysts have trimmed their fair value estimate for Crocs shares by approximately $2, reflecting cautious views on U.S. demand headwinds and promotional pullbacks that, while pressuring near term results, are expected to support healthier margins and a lower future earnings multiple over time. Analyst Commentary Analysts remain divided on Crocs, balancing concern over near term demand softness with recognition that current strategic moves could enhance the brand and earnings quality over time.
Actualización de narrativa Sep 17

Asia And Europe Expansion Will Secure Lasting Market Strength

Analysts lowered their price target for Crocs from $91.83 to $87.83 amid concerns about softening sales growth, U.S. consumer demand shifts, macro headwinds, and ongoing pressure from the HEYDUDE brand, despite some optimism over management's reaffirmed guidance and leadership changes. Analyst Commentary Ongoing concerns about muted sales growth, limited visibility into revenue recovery through 2026, and challenging U.S. market trends are prompting downward price target revisions and rating downgrades by bearish analysts.
Artículo de análisis Aug 14

Crocs' (NASDAQ:CROX) Conservative Accounting Might Explain Soft Earnings

Investors were disappointed with the weak earnings posted by Crocs, Inc. ( NASDAQ:CROX ). However, our analysis...
Actualización de narrativa Aug 08

Asia And Europe Expansion Will Secure Lasting Market Strength

The sharp downward revision in Crocs’ analyst price target reflects materially lowered revenue growth expectations, despite improved net profit margins, leading to a reduced fair value of $95.08. What's in the News Crocs, Inc.
Seeking Alpha Apr 22

Crocs: Long-Term Opportunity Outweighs Short-Term Uncertainty

Summary Despite recent stock declines, I remain optimistic about Crocs due to its strong historical performance, revenue growth, and exceptional margins. Trump's tariffs pose short-term risks, but Crocs' competitive pricing and expanding product lines position it well for long-term success. Crocs' valuation is attractive, with a forward P/E ratio significantly lower than industry peers, indicating potential undervaluation. I believe Crocs' experienced management and innovative strategies will drive future growth, making it a compelling buy for patient, long-term investors. Read the full article on Seeking Alpha
Seeking Alpha Mar 18

Crocs Is Positioned For Long-Term Outperformance

Summary Crocs' core shoe business remains high-quality with respectable growth prospects, trading at an EV/EBIT multiple of less than 8x, suggesting significant undervaluation. The HEYDUDE acquisition has been challenging, but the core Crocs brand's impressive operating and financial metrics justify a higher stock price. The free cash flow from Crocs' core brand and the company's share buyback plans make it an attractive investment with significant potential outperformance prospects. Any value from the HEYDUDE brand is essentially a bonus, making CROX stock a compelling buy with minimal downside risk. Read the full article on Seeking Alpha
Nueva narrativa Feb 22

Predicting a Steady Future for Crocs with Modest Growth and a 10% Discount Rate

International Expansion - Crocs continues to see growth in Asia and Europe, with opportunities to further penetrate emerging markets.
Seeking Alpha Feb 12

Down 50% In 8 Months, Is Crocs Stock A Buy Ahead Of Earnings?

Summary Crocs, Inc. stock has tumbled by nearly 50% since June 2024, underperforming industry peers and the broader stock market. Despite producing lackluster growth numbers in recent quarters, Crocs' strong free cash flow generation (optionality) and strategic investments in brand growth support long-term business potential. Wall Street analysts remain bullish on CROX, with a consensus price target implying ~50% upside and TQI's fair value estimate suggesting +102% potential. With a 5-year price target of ~$335 per share, CROX offers an asymmetric CAGR return of 30%+. In this note, we preview CROX's Q4 2024 report, and re-evaluate its long-term risk/reward. Read the full article on Seeking Alpha
Seeking Alpha Jan 12

Crocs May Have Finally Bottomed

Summary Crocs is rated a Buy due to signs of a bullish trend reversal and improving financial metrics, despite past struggles with the HEYDUDE acquisition. The stock shows potential for significant upside, with technical patterns indicating a possible breakout and historical momentum indicators supporting bullish moves. Crocs' international business is growing, and the balance sheet has improved, but HEYDUDE remains a drag on margins and overall performance. At 8.8X forward earnings, Crocs is fairly valued, with potential for multiple expansion if operating margins improve and HEYDUDE stabilizes. Read the full article on Seeking Alpha
Seeking Alpha Dec 12

Crocs' Valuation Can Be Capitalized On In The Near Term

Summary Crocs' post-pandemic growth has slowed, making it less suited for long-term growth investors but appealing as a two-year value play with a projected EV CAGR of ~15%. The valuation model assumes 3.5% revenue growth, EBITDA margin at 26%, and EV-to-EBITDA expansion to 9.5, yielding a December 2026 EV of $10.783 billion. International expansion presents opportunities but also risks, as cultural adaptation and competition could affect revenue and margin stability. Read the full article on Seeking Alpha
Seeking Alpha Nov 20

Crocs: Near-Term Pressures May Keep The Stock In Check

Summary Crocs stock dipped ~19% despite better-than-expected results due to lower HEYDUDE performance expectations and EBIT margin pressure for 2025. Management's focus on brand building over performance marketing for HEYDUDE will likely lead to higher SG&A expenses and slower revenue growth in the near term. Historical guidance cuts for HEYDUDE raise concerns about market perception of future guidance, potentially limiting investor excitement. The strong USD poses a headwind for Q4 ’24 revenue and profitability, adding to near-term challenges despite the stock's cheap valuation. Read the full article on Seeking Alpha
Seeking Alpha Oct 30

Crocs' Q3: Smart Capital Allocation & Cheap Valuation Outweigh HEYDUDE Headwinds - Buy The Dip

Summary Shares of Crocs plunged 19% due to HEYDUDE's ongoing struggles, but I see this as a buying opportunity given Crocs' overall investment case. Despite HEYDUDE's disappointing performance, Crocs' profitability remains robust, with expanding gross margins and record adjusted EPS expected for the year. Crocs' healthy free cash flow profile and balanced capital allocation plan, including debt repayment and share buybacks, improve the stock's appeal. In the meantime, the stock's attractive valuation signals upside potential, with Crocs being one of the cheapest players in the footwear space. Read the full article on Seeking Alpha
Seeking Alpha Sep 24

Crocs: A Value Play Despite Uncertainties

Summary Crocs' strong financials and competitive advantage are overshadowed by HEYDUDE's poor performance, yet the stock remains undervalued with a promising risk-return ratio. Conservative DCF models project a 19% upside for Crocs, with EPS and operating margins expected to improve gradually. Risks include HEYDUDE's stabilization and potential shifts in trends, but Crocs' low multiples and solid fundamentals present an attractive investment. Read the full article on Seeking Alpha

Desglose de ingresos y gastos

Cómo gana y gasta dinero Crocs. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

NasdaqGS:CROX Ingresos, gastos y beneficios (USD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Jun 264,0555931,40130
31 Mar 264,025-1041,38430
31 Dec 254,041-811,38430
30 Sep 254,0731831,39226
30 Jun 254,1392371,38026
31 Mar 254,1019581,33826
31 Dec 244,1029501,29126
30 Sep 244,0728351,24921
30 Jun 244,0568121,19321
31 Mar 244,0177951,14021
31 Dec 233,9627931,11021
30 Sep 233,9476771,0870
30 Jun 233,8876691,0570
31 Mar 233,7796171,0040
31 Dec 223,55554092919
30 Sep 223,1965579030
30 Jun 222,8375418230
31 Mar 222,5137007730
31 Dec 212,3137267160
30 Sep 212,13875462810
30 Jun 211,87466356610
31 Mar 211,56540049010
31 Dec 201,3863134950
30 Sep 201,23714945812
30 Jun 201,18812344812
31 Mar 201,21610646612
31 Dec 191,23111945812
30 Sep 191,184-1143214
30 Jun 191,132-4142714
31 Mar 191,101-5542214
31 Dec 181,088-6944814
30 Sep 181,0711743213
30 Jun 181,054942713
31 Mar 181,039-143313
31 Dec 171,024-545613
30 Sep 171,012-234793
30 Jun 171,014-264786
31 Mar 171,025-314749
31 Dec 161,036-3246412
30 Sep 161,058-6346223
30 Jun 161,086-8647720
31 Mar 161,108-8749517
31 Dec 151,091-9851514
30 Sep 151,088-765160

Ingresos de calidad: CROX tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (14.6%) de CROX son superiores a los del año pasado (5.7%).


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de CROX han disminuido en un 13.3% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de CROX en el último año (150.9%) supera su media de 5 años (-13.3% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de CROX en el último año (150.9%) superó al de la industria Luxury 31.2%.


Rentabilidad financiera

Alta ROE: La rentabilidad financiera (42.9%) de CROX se considera excepcional.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/08/12 03:50
Precio de las acciones al final del día2026/08/12 00:00
Beneficios2026/06/30
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Crocs, Inc. está cubierta por 24 analistas. 13 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Jonathan KompBaird
Adrienne Yih-TennantBarclays
Aubrey TianelloBNP Paribas